vasopressin V2 receptor agonists (Astellas)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namevasopressin V2 receptor agonists (Astellas)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVasopressin V2 receptor agonists
TargetsVasopressin V2 receptor
Therapy Area/IndicationsNocturiaDiabetes Insipidus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstellas Pharma Inc
Active IndicationsN/A
Inactive IndicationsNocturiaDiabetes Insipidus

Other Information

ATC CodeN/A
Related LinksN/A